Use of randomised trials to decide when to monitor response to new treatment.
Where this comes from
- Record sourced from PubMed, PMID 18276713.
- Also identified by DOI 10.1136/bmj.39476.623611.25 and PMC identifier 2244786.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Is monitoring initial response to treatment always helpful in clinical management of patients? <b>Bell and colleagues</b> have developed a framework for deciding whether surrogate outcomes should be used to monitor initial response to treatment in chronic disease.
Medical subject headings
- Chronic Disease
- Randomized Controlled Trials as Topic